share_log

醫渡科技：翌日披露報表

YIDU TECH: Next Day Disclosure Return

Hong Kong Stock Exchange ·  Apr 16 07:35
Summary by Moomoo AI
医渡科技有限公司於2024年4月16日提交了翌日披露報表，披露其已發行股本出現變動。該公司於同日購回423,400股普通股，佔其已發行股份的0.0399%。購回的股份每股價格介乎HKD 3.37至HKD 3.46，總支付金額為HKD 1,443,243.58。購回後，医渡科技的結存股份總數維持在1,062,040,859股。根據香港聯合交易所有限公司證券上市規則，公司已完成所有必要的法律程序及文件存檔，並確認購回行動符合規定。
医渡科技有限公司於2024年4月16日提交了翌日披露報表，披露其已發行股本出現變動。該公司於同日購回423,400股普通股，佔其已發行股份的0.0399%。購回的股份每股價格介乎HKD 3.37至HKD 3.46，總支付金額為HKD 1,443,243.58。購回後，医渡科技的結存股份總數維持在1,062,040,859股。根據香港聯合交易所有限公司證券上市規則，公司已完成所有必要的法律程序及文件存檔，並確認購回行動符合規定。
MEDU TECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 16, 2024 DISCLOSING CHANGES IN ITS ISSUED SHARE CAPITAL. The company repurchased 423,400 shares of common stock on the same day, representing 0.0399% of its issued shares. The repurchased shares are priced from HKD 3.37 to HKD 3.46 for a total payment of HKD 1,443,243.58. After the repurchase, Medidu Technology's total outstanding shares remained at 1,062,040,859 shares. Pursuant to the Listing Rules of the Hong Kong Stock Exchange Limited, the Company has completed all necessary legal procedures and documentation and confirmed the compliance of the repurchase transaction.
MEDU TECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 16, 2024 DISCLOSING CHANGES IN ITS ISSUED SHARE CAPITAL. The company repurchased 423,400 shares of common stock on the same day, representing 0.0399% of its issued shares. The repurchased shares are priced from HKD 3.37 to HKD 3.46 for a total payment of HKD 1,443,243.58. After the repurchase, Medidu Technology's total outstanding shares remained at 1,062,040,859 shares. Pursuant to the Listing Rules of the Hong Kong Stock Exchange Limited, the Company has completed all necessary legal procedures and documentation and confirmed the compliance of the repurchase transaction.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more